{"id":4779,"date":"2025-02-21T11:55:27","date_gmt":"2025-02-21T01:55:27","guid":{"rendered":"\/eu-uk\/?p=4779"},"modified":"2025-02-21T12:28:35","modified_gmt":"2025-02-21T02:28:35","slug":"thailand-regulatory-application-for-remplir","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/02\/21\/thailand-regulatory-application-for-remplir\/","title":{"rendered":"Thailand Regulatory Application for Remplir\u2122"},"content":{"rendered":"<p>Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n<p>This is an important milestone in our global expansion plans for Remplir\u2122, with the Thailand nerve repair market representing an $84M opportunity.<\/p>\n<p>Remplir is now gaining record sales traction in Australia, New Zealand and Singapore, with all sights set on US FDA clearance in March\/April 2025.<\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC_ThailandRegulatoryApplication\">Click to read the ASX Release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n","protected":false},"author":2,"featured_media":4781,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4779"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4779\/revisions"}],"predecessor-version":[{"id":4780,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4779\/revisions\/4780"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4781"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4779"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}